Kabra Drugs informs about compliance certificate

08 Apr 2022 Evaluate
Kabra Drugs has informed that Kabra Drugs having CIN: L02423MP1989LC005438, has authorized to Skyline Financial Services, Share Transfer Agent, registered with SEBI vide registration number INR000003241 for all activities in relation for both Physical and Electronic Transfer facility for the year ended 31.03.2022, under regulation 7(2) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015. The certificate has issued in compliance of regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Kabra Drugs Share Price

26.95 -0.03 (-0.11%)
22-Jan-2026 10:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1640.35
Dr. Reddys Lab 1219.35
Cipla 1380.00
Zydus Lifesciences 885.90
Lupin 2188.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×